Pain Management Drugs and Devices Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

“Pain Management Drugs and Devices”
Pain Management Drugs and Devices -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast to 2023

Pain Management Drugs and Devices Industry


Wiseguyreports.Com Adds “Pain Management Drugs and Devices -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast to 2023” To Its Research Database

Global Pain Management Drugs and Devices Market is accounted for $41.73 billion in 2016 and is expected to reach $61.52 billion by 2023 growing at a CAGR of 5.7% during the forecast period. Growing healthcare industry across the globe, rapid technological developments and increasing various pain disorders tied with rising global geriatric people are some of the key factors propelling the market growth. However, factors such as availability of alternative therapies, drug abuse and patent expiration of prescription drugs are hindering the market.

Neuromodulation is technology that is used for the alteration or modulation of the nerve activity by using chemical agents or electrical stimulation to the specific neurological sites in the body. Most of the neuromodulation devices work through electrical stimulation. Neuromodulation devices are used by the application of electrodes to the brain, peripheral nerves or the spinal cord. The electrode leads in neuromodulation devices are connected through an extension cable to a power source and pulse generator, which generates required electrical impulses. North America is anticipated to hold the largest market share due to the rising incidence of chronic diseases, increasing government support, growing middle-class population and disposable income levels in this region.

Some of the key players in the Pain Management Drugs and Devices Market include Abbott Laboratories, Endo International, Abbvie, DJO Global Inc., Johnson & Johnson, Novartis International AG, Grunenthal Gmbh, ELI Lilly & Co, Hisamitsu Pharmaceutical Co. Inc., Pfizer Inc., Astrazeneca Plc, Purdue Pharma LP, Glaxosmithkline, Medtronic and Boston Scientific Corp.

Device Types Covered: 
• Neuromodulation Devices 
• Analgesic Infusion Pumps 
• Ablation Devices 
• Electrical stimulation devices

Request for Sample Report @

Drug Classes Covered: 
• Non-Narcotic Analgesics 
• Narcotic Pain Management 
• Opioids 
• Antidepressent 
• Anesthetics 
• Anticovulsants 
• Anti-Migraine Agents 
• Other Drug Classes 

Applications Covered: 
• General Pain 
• Dental Pain 
• HIV/AIDS Pain 
• Migraine Pain 
• Orthopedic/Musculoskeletal Pain 
• Neuropathic Pain 
• Cancer Pain 
• Fibromyalgia Pain 
• Surgical Pain 
• Other Applications

Indications Covered: 
• Arthritic Pain 
• Chronic back pain

Mode of Purchases Covered: 
• Over-the-counter Devices 
• Over-the-counter Devices

Regions Covered: 
• North America 
o US 
o Canada 
o Mexico 
• Europe 
o Germany 
o UK 
o Italy 
o France 
o Spain 
o Rest of Europe 
• Asia Pacific 
o Japan 
o China 
o India 
o Australia 
o New Zealand 
o South Korea 
o Rest of Asia Pacific 
• South America 
o Argentina 
o Brazil 
o Chile 
o Rest of South America 
• Middle East & Africa 
o Saudi Arabia 
o UAE 
o Qatar 
o South Africa 
o Rest of Middle East & Africa

What our report offers: 
– Market share assessments for the regional and country level segments 
– Market share analysis of the top industry players 
– Strategic recommendations for the new entrants 
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
– Strategic recommendations in key business segments based on the market estimations 
– Competitive landscaping mapping the key common trends 
– Company profiling with detailed strategies, financials, and recent developments 
– Supply chain trends mapping the latest technological advancements

Leave a Query @


Table of Content

1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Application Analysis 
3.7 Emerging Markets 
3.8 Futuristic Market Scenario 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 


11 Key Developments 
11.1 Agreements, Partnerships, Collaborations and Joint Ventures 
11.2 Acquisitions & Mergers 
11.3 New Product Launch 
11.4 Expansions 
11.5 Other Key Strategies 

12 Company Profiling 
12.1 Abbott Laboratories 
12.2 Endo International 
12.3 Abbvie 
12.4 DJO Global Inc. 
12.5 Johnson & Johnson 
12.6 Novartis International AG 
12.7 Grunenthal Gmbh 
12.8 ELI Lilly & Co. 
12.9 Hisamitsu Pharmaceutical Co. Inc. 
12.10 Pfizer Inc. 
12.11 Astrazeneca Plc 
12.12 Purdue Pharma LP 
12.13 Glaxosmithkline 
12.14 Medtronic 
12.15 Boston Scientific Corp 

Buy now @


Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)


Media Contact
Company Name:
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India